25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D site in Gothenburg, Sweden from 14–15 May.

24 March 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of the first inspection by the French regulatory authority, ANSM (Agence nationale de sécurité du médicament et des produits de santé), at its state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France.

18 March 2025 -- Indianapolis, US -- Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation, revolutionizes spectral flow cytometry with the industry’s first modular solution: the CytoFLEX mosaic Spectral Detection Module.

18 March 2025 -- Massachusetts, US -- Thermo Fisher Scientific Inc, the world leader in serving science, today announced the launch of the Thermo Scientific Vulcan Automated Lab, a groundbreaking solution designed to drive a new era of process development and control in semiconductor manufacturing. The seamlessly integrated system is designed to enhance productivity, increase yield and reduce operating costs for semiconductor manufacturers.

13 March 2025 -- Massachusetts, US -- Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced today that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group (HKG:0806), one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors, as well as continued support from global existing backers.

12 March 2025 -- Basel, Switzerland -- Celonic Group has announced that it is integrating Merck’s Breez micro-bioreactor platform into its process development. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by enabling highly efficient, scalable perfusion-based bioprocessing from early-stage development to large-scale manufacturing.

11 March 2025 -- North Carolina, US -- Merck, known as MSD outside of the United States and Canada, announced today the opening of a new, $1billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site.

A second edition of the LASER COMPONENTS Pyroelectric Receiver series is now available!

When you are limited in space and weight, FLEXPOINT® MVpico laser modules with a uniform line from LASER COMPONENTS guarantee a high performance. These small line laser modules come at various wavelengths from 405 to 850nm and with an output power up to 100mW, suitable for many applications.

4 March 2025 -- Porto, Portugal, and California, US -- FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco site from Charles River Laboratories International, Inc.

LASER COMPONENTS is pleased to announce that Cybel's fibre lasers and amplifiers are now available to customers in the medical, aerospace, defense, quantum technology and LiDAR industries. Products by this US-based manufacturer are used in applications that require precisely preset wavelengths.

13 February 2025 -- Manchester, UK -- Yourgene Health, a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal screening service for genetic conditions, in the UK.